Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-31 4:05 pm Unchanged | 2022-08-08 | 13G | Pliant Therapeutics, Inc. PLRX | Novartis Institutes for BioMedical Research Inc. | 2,153,526 4.400% | 0 (Unchanged) | Filing |